Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Evaluation of Long-term Safety and Efficacy of ELX/TEZ/IVA in Cystic Fibrosis Participants 12 Months of Age and OlderCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, hereditary disease, lung disorder, pancreas disorder, respiratory system disorderActive, not recruitingPhase 32026-06-05NCT06460506

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Vertex Pharmaceuticals Incorporated37

18 results · Page 1 of 1

Swipe the table sideways for more columns.